|
Children's Oncology Group Statistics and Data Center
|
5U10CA098413-05
|
$5,859,839
|
$175,795
|
ANDERSON, JAMES
|
NATIONAL CHILDHOOD CANCER FOUNDATION
|
|
Descriptive Studies and Record Linkage
|
Z01 CP010183
|
$674,691
|
$4,375
|
Anderson
|
DCEG (NCI)
|
|
Role of Polyamines in MYCN-Amplified Neuroblastoma
|
3R01CA111419-02S1
|
$71,738
|
$71,738
|
BACHMANN, ANDRE
|
UNIVERSITY OF HAWAII AT MANOA
|
|
Role of Polyamines in MYCN-Amplified Neuroblastoma
|
5R01CA111419-02
|
$214,682
|
$214,682
|
BACHMANN, ANDRE
|
UNIVERSITY OF HAWAII AT MANOA
|
|
Drug Development and Clinical Pharmacology of Anticancer Drugs for Childhood Canc
|
Z01 SC 006880
|
$1,453,500
|
$290,700
|
Balis, Frank
|
CCR (NCI)
|
|
Geisinger Clinical Oncology Program
|
5U10CA035448-24
|
$458,852
|
$4,589
|
BERNATH, ALBERT
|
GEISINGER MEDICAL CENTER
|
|
Cancer Center Support Grant
|
3P30CA072720-11S1
|
$108,846
|
$1,088
|
BERTINO, JOSEPH
|
UNIV OF MED/DENT NJ-R W JOHNSON MED SCH
|
|
Cancer Center Support Grant
|
3P30CA072720-11S2
|
$127,296
|
$1,273
|
BERTINO, JOSEPH
|
UNIV OF MED/DENT NJ-R W JOHNSON MED SCH
|
|
Cancer Center Support Grant
|
5P30CA072720-11
|
$3,128,377
|
$31,284
|
BERTINO, JOSEPH
|
UNIV OF MED/DENT NJ-R W JOHNSON MED SCH
|
|
Neuroblastoma Biology and Therapy
|
5P01CA097323-05
|
$2,216,467
|
$2,216,467
|
BRODEUR, GARRETT
|
CHILDREN'S HOSPITAL OF PHILADELPHIA
|
|
N-myc Targeted Therapeutics for Childhood Neuroblastoma
|
5R44CA110885-03
|
$396,999
|
$396,999
|
Burkhart, Catherine
|
CLEVELAND BIOLABS, INC.
|
|
Specialized Cancer Center Support Grant
|
2P30CA023100-23
|
$3,966,000
|
$79,320
|
CARSON, DENNIS
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
Specialized Cancer Center Support Grant
|
3P30CA023100-23S1
|
$115,875
|
$2,318
|
CARSON, DENNIS
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
Specialized Cancer Center Support Grant
|
3P30CA023100-23S2
|
$92,700
|
$1,854
|
CARSON, DENNIS
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
A novel set of molecular markers to measure metastatic neuroblastoma
|
5R21CA118845-02
|
$132,978
|
$132,978
|
CHEUNG, NAI-KONG
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
|
Microenvironmental Regulation of Tumor Progression
|
5R01CA098075-05
|
$319,620
|
$47,943
|
COUSSENS, LISA
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
|
Developmental Signal Transduction in Xenopus Oocytes and Embryos
|
Z01 BC 010006
|
$689,247
|
$34,462
|
Daar, Ira
|
CCR (NCI)
|
|
Selective Therapy of Neuroblastoma
|
5R01CA079763-09
|
$213,341
|
$213,341
|
DANKS, MARY
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Neural Progenitor Cells as Cancer Therapy Vectors
|
5R01CA113446-03
|
$331,343
|
$331,343
|
DANKS, MARY
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
The oncogenic basis of Bmi-1 in neuroblastoma development
|
1R01CA124982-01A1
|
$281,770
|
$281,770
|
DING, HAN-FEI
|
UNIVERSITY OF TOLEDO HEALTH SCI CAMPUS
|
|
YALE COMPREHENSIVE CANCER CENTER
|
2P30CA016359-29
|
$1,871,000
|
$18,710
|
EDELSON, RICHARD
|
YALE UNIVERSITY
|
|
"Infections, immunity, and inflammation in cancer"
|
Z01 CP010150
|
$726,292
|
$800
|
Engels
|
DCEG (NCI)
|
|
Center of Nanotechnology for Treatment, Understanding, *
|
3U54CA119335-03S1
|
$58,129
|
$2,906
|
ESENER, SADIK
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
Center of Nanotechnology for Treatment, Understanding, *
|
3U54CA119335-03S2
|
$58,129
|
$2,906
|
ESENER, SADIK
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
Center of Nanotechnology for Treatment, Understanding, *
|
5U54CA119335-03
|
$3,902,354
|
$195,118
|
ESENER, SADIK
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
GENETIC ELEMENTS TRANSFORMING MOUSE FIBROBLASTS
|
5R01CA060730-13
|
$183,900
|
$25,746
|
GUDKOV, ANDREI
|
CLEVELAND CLINIC LERNER COL/MED-CWRU
|
|
GENETIC ELEMENTS TRANSFORMING MOUSE FIBROBLASTS
|
7R01CA060730-14
|
$106,838
|
$14,957
|
GUDKOV, ANDREI
|
ROSWELL PARK CANCER INSTITUTE CORP
|
|
Studies of Childhood Solid Tumors
|
2P01CA023099-29
|
$2,156,053
|
$215,605
|
HOUGHTON, PETER
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
mTOR Signaling in Tumor Cell Motility
|
5R01CA115414-02
|
$201,997
|
$40,399
|
Huang, Shile
|
LOUISIANA STATE UNIV HSC SHREVEPORT
|
|
Cancer Center Support (Core) Grant
|
5P30CA014051-36
|
$2,815,899
|
$28,159
|
JACKS, TYLER
|
MASSACHUSETTS INSTITUTE OF TECHNOLOGY
|
|
Optimizing Immunotherapy for Neuroblastoma after BMT
|
5R01CA100030-04
|
$291,566
|
$291,566
|
JOHNSON, BRYON
|
MEDICAL COLLEGE OF WISCONSIN
|
|
St.Jude Children's Cancer Center Support Grant (CCSG)
|
3P30CA021765-29S2
|
$5,331,937
|
$426,555
|
KASTAN, MICHAEL
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
St.Jude Children's Cancer Center Support Grant (CCSG)
|
3P30CA021765-29S3
|
$98,400
|
$7,872
|
KASTAN, MICHAEL
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Comparative Genomic Hybridization of Neuroblastoma
|
Z01 BC 010592
|
$175,175
|
$175,175
|
Khan, Javed
|
CCR (NCI)
|
|
Molecular Mechanisms of Drugs
|
Z01 BC 010594
|
$87,588
|
$70,070
|
Khan, Javed
|
CCR (NCI)
|
|
Targeting High-risk Neuroblastoma using high through put siRNA screening
|
Z01 BC 010806
|
$218,969
|
$120,433
|
Khan, Javed
|
CCR (NCI)
|
|
Identification of Genes for Predicting Prognosis in Pediatric Cancers
|
Z01 SC 010366
|
$218,969
|
$153,278
|
Khan, Javed
|
CCR (NCI)
|
|
Neuropeptide Y in neuroblastoma: growth, angiogenesis and future therapeutics.
|
5R01CA123211-02
|
$265,208
|
$265,208
|
KITLINSKA, JOANNA
|
GEORGETOWN UNIVERSITY
|
|
Nanodosing: A path to higher sensitivity and lower toxicity pharmaceuticals
|
1R44CA130394-01
|
$130,761
|
$65,381
|
Kronauge, James
|
MOLECULAR INSIGHT PHARMACEUTICALS, INC.
|
|
Developing Nanodosing of Iobenguane I 131 for Radiotherapy
|
5R44CA115120-03
|
$351,359
|
$87,840
|
Kronauge, James
|
MOLECULAR INSIGHT PHARMACEUTICALS, INC.
|
|
Transcriptional regulation of NC precursor formation
|
5R01CA114058-03
|
$198,982
|
$99,491
|
LABONNE, CAROLE
|
NORTHWESTERN UNIVERSITY
|
|
Gangliosides and the Biology of Human Neuroblastoma
|
5R01CA042361-16
|
$261,674
|
$209,339
|
LADISCH, STEPHAN
|
CHILDREN'S RESEARCH INSTITUTE
|
|
Complex ganglioside function in neuroblastoma
|
5R01CA106532-03
|
$247,903
|
$247,903
|
LADISCH, STEPHAN
|
CHILDREN'S RESEARCH INSTITUTE
|
|
Apoptotic Pathway Defects in Neuroblastoma
|
5R01CA067938-11
|
$320,011
|
$320,011
|
LAHTI, JILL
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
South Texas Pediatric Minority Based CCOP
|
3U10CA052771-17S1
|
$75,000
|
$2,250
|
LANGEVIN, ANNE-MARIE
|
UNIVERSITY OF TEXAS HLTH SCI CTR SAN ANT
|
|
South Texas Pediatric Minority Based CCOP
|
5U10CA052771-17
|
$360,000
|
$10,800
|
LANGEVIN, ANNE-MARIE
|
UNIVERSITY OF TEXAS HLTH SCI CTR SAN ANT
|
|
Methods for genomic data with graphical structures
|
1R01CA127334-01
|
$292,160
|
$29,216
|
Li, Hongzhe
|
UNIVERSITY OF PENNSYLVANIA
|
|
CHEMISTRY AND BIOLOGY OF PLATINUM ANTICANCER DRUGS
|
5R37CA034992-25
|
$665,514
|
$133,103
|
LIPPARD, STEPHEN
|
MASSACHUSETTS INSTITUTE OF TECHNOLOGY
|
|
Prevention of neuroblastoma with histone deacetylase inhibitors
|
1R03CA128075-01
|
$54,000
|
$54,000
|
LIU, Tao
|
UNIVERSITY OF NEW SOUTH WALES
|
|
Neuroblastoma Tumor Suppressor Genes in Zebrafish
|
5R01CA104605-04
|
$332,386
|
$332,386
|
LOOK, A
|
DANA-FARBER CANCER INSTITUTE
|
Total relevant funding to Neuroblastoma for this search: $17,743,262
|